[HTML][HTML] Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
Y Wang, Y Wang, Y Ren, Q Zhang, P Yi… - Seminars in cancer …, 2022 - Elsevier
Cytotoxic T-lymphocyte–associated antigen-4 (CTLA-4) or programmed death-1 (PD-
1)/programmed death-ligand 1 (PD-L1)–based immune checkpoint inhibitors (ICIs) have led …
1)/programmed death-ligand 1 (PD-L1)–based immune checkpoint inhibitors (ICIs) have led …
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
Y Wang, Y Wang, Y Ren, Q Zhang… - Seminars in cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) or programmed death-1 (PD-
1)/programmed death-ligand 1 (PD-L1)-based immune checkpoint inhibitors (ICIs) have led …
1)/programmed death-ligand 1 (PD-L1)-based immune checkpoint inhibitors (ICIs) have led …
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer.
Y Wang, Y Ren, Q Zhang, P Yi… - Seminars in Cancer …, 2022 - europepmc.org
Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) or programmed death-1 (PD-
1)/programmed death-ligand 1 (PD-L1)-based immune checkpoint inhibitors (ICIs) have led …
1)/programmed death-ligand 1 (PD-L1)-based immune checkpoint inhibitors (ICIs) have led …